MetaCap

Clover Health Investments Corp. Class A (CLOV)

NASDAQ: CLOVHealth CareMedical SpecialitiesUSD

3.73-0.04 (-1.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLOV stock chart

Technical analysis

Key statistics

All statistics
P/E (TTM)
373.00
52-week range
1.58 – 5.59
Day range
3.68 – 3.96
Volume / Avg
7.24M / 4.49M
Beta
—

52-week range

$1.58$5.59

CLOV stock today

On Nov 20, CLOV ended the session at $3.73, shedding $0.04 (1.06%), versus the S&P 500's 3.70% decline. At this level, CLOV sits in the middle of its 52-week range of $1.58 to $5.59: 33.3% below the high, set on Jun 29, 2026 and 136.1% above the low. CLOV is up 58.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 63.6%.

At 373.0x trailing earnings, Clover Health Investments trades above the peer-group median of 45.5x. Its forward P/E of 20.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Clover Health Investments

Company profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.

Industry
Medical Specialities
CEO
Mr. Andrew Toy
Headquarters
Wilmington, DE
Employees
724

Financial highlights

Full financials

In fiscal 2025, Clover Health Investments generated $1.92 billion in revenue, up 40.3% from fiscal 2024, its 3rd consecutive year of revenue growth. Clover Health Investments reported a net loss of $85.5 million, compared with a loss of $43.0 million a year earlier. Operating margin was -4.4%.

Clover Health Investments annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.92B$1.37B$1.26B$1.10B$1.47B
Growth+40.34%+8.77%+14.96%-25.51%+118.76%
Net income$-85.55M$-43.01M$-213.36M$-339.57M$-587.76M
EPS (diluted)$-0.17$-0.09$-0.44$-0.71$-1.42

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$5.60+50.13%

  • Strong buy 1
  • Buy 2
  • Hold 2
  • Sell 0
  • Strong sell 0

Target range

Low $5.00High $6.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$-0.05 vs $-0.01
Surprise
-400.00%

CLOV news

All CLOV news

Clover Health Investments peers

Health Care sector
CLOV peer companies
CompanyPrice% ChgMarket capCompare
VCYTVeracyte Inc.25.13+0.36%$2.03Bvs CLOV
FTREFortrea Holdings Inc.18.55-7.94%$1.79Bvs CLOV
PSNLPersonalis Inc.14.27-3.06%$1.55Bvs CLOV
TRUPTrupanion Inc.35.56-0.86%$1.54Bvs CLOV
CELCCelcuity Inc.53.35-5.26%$2.61Bvs CLOV
LMRILumexa Imaging Holdings Inc.14.26+1.42%$1.37Bvs CLOV
ALHCAlignment Healthcare Inc.6.37-2.00%$1.33Bvs CLOV
FRNMFreenome Inc.9.36-5.69%$1.04Bvs CLOV

Indexes, lists and sector

Clover Health Investments stock FAQ

What is Clover Health Investments's stock price today?

CLOV last traded at $3.73 as of Nov 20, 4:00 PM EST, down 1.06% on the day. Prices are delayed at least 15 minutes.

What is CLOV's P/E ratio?

CLOV trades at a trailing P/E ratio of 373.00 and a forward P/E of 20.72, compared with a median of 45.5 for its closest peers.

Who is Clover Health Investments's CEO?

Mr. Andrew Toy is the chief executive officer of Clover Health Investments Corp. Class A, which has about 724 employees.

What is the CLOV 52-week high?

The 52-week high for CLOV is $5.59 and the 52-week low is $1.58. The stock is currently 33.3% below its high.

Compare CLOV